Literature DB >> 19094434

Decline in pneumonia and acute otitis media after the introduction of childhood pneumococcal vaccination in Liguria, Italy.

F Ansaldi1, L Sticchi, P Durando, R Carloni, P Oreste, M Vercelli, P Crovari, G Icardi.   

Abstract

The effect of the pneumococcal conjugate vaccine immunization programme on pneumococcal-associated or potentially pneumococcal-associated hospital admissions in the Italian region of Liguria was assessed. Hospital admission rates were compared in subjects belonging to birth cohorts before and after the introduction of widespread immunization for 0 - 2-year old children with a seven-valent conjugate vaccine (PCV7). Significant reductions in hospitalization rates for all-cause and pneumococcal pneumonia and for acute otitis media were observed in subjects born after widespread uptake of the vaccine. The preventive fraction (a measure of vaccine effectiveness) ranged from 15.2% for all cause pneumonia to 70.5% for pneumococcal pneumonia. This study contributes to the growing body of information that supports the beneficial effect of PCV7 vaccination.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19094434     DOI: 10.1177/147323000803600612

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


  11 in total

Review 1.  The impact of new vaccine introduction on immunization and health systems: a review of the published literature.

Authors:  Terri B Hyde; Holly Dentz; Susan A Wang; Helen E Burchett; Sandra Mounier-Jack; Carsten F Mantel
Journal:  Vaccine       Date:  2012-08-29       Impact factor: 3.641

Review 2.  Systematic review of the effect of pneumococcal conjugate vaccine dosing schedules on prevention of pneumonia.

Authors:  Jennifer D Loo; Laura Conklin; Katherine E Fleming-Dutra; Maria Deloria Knoll; Daniel E Park; Jennifer Kirk; David Goldblatt; Katherine L O'Brien; Cynthia G Whitney
Journal:  Pediatr Infect Dis J       Date:  2014-01       Impact factor: 2.129

3.  Rise of multidrug-resistant non-vaccine serotype 15A Streptococcus pneumoniae in the United Kingdom, 2001 to 2014.

Authors:  Carmen Sheppard; Norman K Fry; Shazad Mushtaq; Neil Woodford; Rosy Reynolds; Regina Janes; Rachel Pike; Robert Hill; Maimuna Kimuli; Peter Staves; Michel Doumith; Timothy Harrison; David M Livermore
Journal:  Euro Surveill       Date:  2016-12-15

4.  Reduction in all-cause otitis media-related outpatient visits in children after PCV10 introduction in Brazil.

Authors:  Ana L Sartori; Ruth Minamisava; Ana L Bierrenbach; Cristiana M Toscano; Eliane T Afonso; Otaliba L Morais-Neto; José L F Antunes; Elier B Cristo; Ana Lucia Andrade
Journal:  PLoS One       Date:  2017-06-08       Impact factor: 3.240

5.  Overall effectiveness of pneumococcal conjugate vaccines: An economic analysis of PHiD-CV and PCV-13 in the immunization of infants in Italy.

Authors:  Paolo Castiglia; Lorenzo Pradelli; Stefano Castagna; Veronica Freguglia; Giorgio Palù; Susanna Esposito
Journal:  Hum Vaccin Immunother       Date:  2017-07-12       Impact factor: 3.452

6.  Routine infant immunization with the 7- and 13-valent pneumococcal conjugate vaccines: current perspective on reduced-dosage regimens.

Authors:  Teresa Jackowska; Justyna Pluta
Journal:  Arch Med Sci       Date:  2012-07-04       Impact factor: 3.318

Review 7.  Prevention of pneumococcal diseases in the post-seven valent vaccine era: a European perspective.

Authors:  Catherine Weil-Olivier; Mark van der Linden; Iris de Schutter; Ron Dagan; Lorenzo Mantovani
Journal:  BMC Infect Dis       Date:  2012-09-07       Impact factor: 3.090

Review 8.  Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis.

Authors:  Harish Nair; Eric Af Simões; Igor Rudan; Bradford D Gessner; Eduardo Azziz-Baumgartner; Jian Shayne F Zhang; Daniel R Feikin; Grant A Mackenzie; Jennifer C Moiïsi; Anna Roca; Henry C Baggett; Syed Ma Zaman; Rosalyn J Singleton; Marilla G Lucero; Aruna Chandran; Angela Gentile; Cheryl Cohen; Anand Krishnan; Zulfiqar A Bhutta; Adriano Arguedas; Alexey Wilfrido Clara; Ana Lucia Andrade; Maurice Ope; Raúl Oscar Ruvinsky; María Hortal; John P McCracken; Shabir A Madhi; Nigel Bruce; Shamim A Qazi; Saul S Morris; Shams El Arifeen; Martin W Weber; J Anthony G Scott; W Abdullah Brooks; Robert F Breiman; Harry Campbell
Journal:  Lancet       Date:  2013-01-29       Impact factor: 79.321

9.  Estimating the Clinical and Economic Impact of Switching from the 13-Valent Pneumococcal Conjugate Vaccine (PCV13) to the 10-Valent Pneumococcal Conjugate Vaccine (PCV10) in Italy.

Authors:  Filippo Ansaldi; Sarah Pugh; Daniela Amicizia; Roberto Di Virgilio; Cecilia Trucchi; Andrea Orsi; Alessandro Zollo; Giancarlo Icardi
Journal:  Pathogens       Date:  2020-01-22

Review 10.  Respiratory risks from household air pollution in low and middle income countries.

Authors:  Stephen B Gordon; Nigel G Bruce; Jonathan Grigg; Patricia L Hibberd; Om P Kurmi; Kin-bong Hubert Lam; Kevin Mortimer; Kwaku Poku Asante; Kalpana Balakrishnan; John Balmes; Naor Bar-Zeev; Michael N Bates; Patrick N Breysse; Sonia Buist; Zhengming Chen; Deborah Havens; Darby Jack; Surinder Jindal; Haidong Kan; Sumi Mehta; Peter Moschovis; Luke Naeher; Archana Patel; Rogelio Perez-Padilla; Daniel Pope; Jamie Rylance; Sean Semple; William J Martin
Journal:  Lancet Respir Med       Date:  2014-09-02       Impact factor: 30.700

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.